BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38088077)

  • 1. [Sleeve Resection for Right Upper Lobe Non-small Cell Lung Cancer After Systemic Chemotherapy and Immune Checkpoint Inhibitor Administration].
    Hashimoto M; Masumoto T; Yoden M; Kaku R; Sawai S; Suzumura Y
    Kyobu Geka; 2023 Dec; 76(13):1110-1114. PubMed ID: 38088077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multimodal treatment of non small cell lung cancer].
    Stoelben E; Digel W; Henke M; Passlick B
    Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of neoadjuvant chemotherapy on complications in patients undergoing surgical treatment for non small cell lung cancer].
    Tomaszewski D; Zajac-Lenczewska I; Plichta L; Lapiński M; Murawski M; Sternau A; Skokowski J
    Pneumonol Alergol Pol; 2004; 72(11-12):477-81. PubMed ID: 16329346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two centres experience of lung cancer resection in patients with advanced non-small cell lung cancer upon treatment with immune checkpoint inhibitors: safety and clinical outcomes.
    Beattie R; Furrer K; Dolan DP; Curioni-Fontecedro A; Lee DN; Frauenfelder T; Hoeller S; Weder W; Bueno R; Opitz I; Swanson S
    Eur J Cardiothorac Surg; 2021 Dec; 60(6):1297-1305. PubMed ID: 34331065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non-small cell lung cancer in the randomized phase III IMpower010 trial.
    Lee JM; Vallières E; Ding B; Johnson A; Bhagwakar J; Rashidi S; Zhu QC; Gitlitz BJ; Weksler B; Costas K; Altorki N
    J Thorac Cardiovasc Surg; 2023 Sep; 166(3):655-666.e7. PubMed ID: 36841745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer.
    Deutsch M; Crawford J; Leopold K; Wolfe W; Foster W; Herndon J; Blackwell S; Yost R
    Cancer; 1994 Aug; 74(4):1243-52. PubMed ID: 8055445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage pulmonary resection in stages IIIb-IV lung cancer after treatment with immune checkpoint inhibitors case series and literature review.
    Smith A; Wali A; Montes A; Hadaki M; Harrison-Phipps K; Karapanagiotou EM; Bille A
    J Surg Oncol; 2022 Feb; 125(2):290-298. PubMed ID: 34569618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally Invasive Lobectomy for Residual Primary Tumors of Advanced Non-Small-Cell Lung Cancer After Treatment With Immune Checkpoint Inhibitors: Case Series and Clinical Considerations.
    Baek J; Owen DH; Merritt RE; Shilo K; Otterson GA; D'Souza DM; Carbone DP; Kneuertz PJ
    Clin Lung Cancer; 2020 Jul; 21(4):e265-e269. PubMed ID: 32184051
    [No Abstract]   [Full Text] [Related]  

  • 9. Sleeve lobectomy for non-small cell lung cancer.
    De Leyn P; Rots W; Deneffe G; Nafteux P; Coosemans W; Van Raemdonck D; Decker G; Lerut T
    Acta Chir Belg; 2003; 103(6):570-6. PubMed ID: 14743560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
    Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
    Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preserving middle lobe to improve lung function in non-small-cell lung cancer.
    Ludwig C; Morand P; Schnell J; Stoelben E
    Asian Cardiovasc Thorac Ann; 2009 Apr; 17(2):153-6. PubMed ID: 19592545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of induction therapy on airway complications after sleeve lobectomy for lung cancer.
    Gonzalez M; Litzistorf Y; Krueger T; Popeskou SG; Matzinger O; Ris HB; Gronchi F; Lovis A; Peters S
    Ann Thorac Surg; 2013 Jul; 96(1):247-52. PubMed ID: 23684158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer.
    Kasprzyk M; Dyszkiewicz W; Piwkowski C; Brudlo M; Galecki B; Gabryel P; Gasiorowski L
    Neoplasma; 2013; 60(1):62-7. PubMed ID: 23067218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term survival of personalized surgical treatment of locally advanced non-small cell lung cancer based on molecular staging].
    Zhou Q; Shi Y; Chen J; Liu B; Wang Y; Zhu D; Zhang HT; Xu P; Gong Y; Chen G; Wei S; Qiu X; Niu Z; Chen X; Lei Z; Duan L; Wu Z
    Zhongguo Fei Ai Za Zhi; 2011 Feb; 14(2):86-106. PubMed ID: 21342639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which patients should be operated on after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7-year experience in 175 patients.
    Stefani A; Alifano M; Bobbio A; Grigoroiu M; Jouni R; Magdeleinat P; Regnard JF
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):356-63. PubMed ID: 20381815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of Lung Autotransplantation for Central Non-small Cell Lung Cancer].
    Mo Y; Lin L; Li Z; Zhong C; Yan J; Kuang J; Yang G; Zhang J
    Zhongguo Fei Ai Za Zhi; 2020 Aug; 23(8):673-678. PubMed ID: 32838489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Video-assisted thoracoscopic surgery is more favorable than thoracotomy for administration of adjuvant chemotherapy after lobectomy for non-small cell lung cancer.
    Jiang G; Yang F; Li X; Liu J; Li J; Zhao H; Li Y; Wang J
    World J Surg Oncol; 2011 Dec; 9():170. PubMed ID: 22185633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer: why pneumonectomy should be avoided.
    Kappers I; van Sandick JW; Burgers SA; Belderbos JS; van Zandwijk N; Klomp HM
    Lung Cancer; 2010 May; 68(2):222-7. PubMed ID: 19664843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival following open versus thoracoscopic lobectomy after preoperative chemotherapy for non-small cell lung cancer.
    Yang CF; Meyerhoff RR; Mayne NR; Singhapricha T; Toomey CB; Speicher PJ; Hartwig MG; Tong BC; Onaitis MW; Harpole DH; D'Amico TA; Berry MF
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1615-23. PubMed ID: 26719408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sacrificing the pulmonary arterial branch to the spared lobe is a risk factor of bronchopleural fistula in sleeve lobectomy after chemoradiotherapy.
    Toyooka S; Soh J; Shien K; Sugimoto S; Yamane M; Oto T; Date H; Miyoshi S
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):568-72. PubMed ID: 22659891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.